Roswell Park Cancer Institute
Breast Cancer Outcomes Show Ties to Neighborhood Income in New Study
In estrogen receptor-positive breast cancer patients, lower income appeared to track with higher tumor expression-based recurrence scores, and shorter survival in the low-risk RS group.
People in the News at Personalis, Roche, Massive Bio, SeqLL, More
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Dec. 12, 2022.
NCI Grants $1.9M to Roswell Park to Study Molecular Race-Based Breast Cancer Disparities
The grant will fund an investigation into long noncoding RNA and the role it plays in differing prognoses between Black and white breast cancer patients.
Roswell Park, Catholic Health, University of Buffalo Partner on Coronavirus Sequencing Study
The study, which is being supported by Thermo Fisher Scientific, aims to identify genetic biomarkers that can predict patients likely to develop severe disease.
Ovarian Cancer Omics Consortium Receives $500K DoD Grant for Early Detection Biomarker Discovery
The consortium is comprised of researchers from Inova, Roswell Park Comprehensive Cancer Center, the Mayo Clinic, and MD Anderson Cancer Center.